Zydus Wellness Ltd (ZYDS)

Currency in INR
554.20
-3.95(-0.71%)
Closed·
ZYDS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
551.40561.35
52 wk Range
367.55611.85
Key Statistics
Bid/Ask
552.00 / 554.20
Prev. Close
554.2
Open
558.25
Day's Range
551.4-561.35
52 wk Range
367.55-611.85
Volume
195.18K
Average Volume (3m)
781.93K
1-Year Change
12.0501%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ZYDS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Zydus Wellness Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
ICICI Securities
Buy630.00+13.68%580.00Maintain05-08-2026
PhillipCapital
Buy500.00-9.78%-New Coverage11-02-2026
Motilal Oswal Securities
Buy575.00+3.75%-New Coverage31-12-2025

Zydus Wellness Ltd Earnings Call Summary for Q1/2027

  • Zydus Wellness Q1 FY2027 net sales surged 66.7% YoY to INR 14.3B; EBITDA rose 55.3% to INR 2.4B despite 7% reported net profit decline.
  • International business drove growth with 24.8% like-to-like gains; domestic sales grew just 4.6% as unseasonal rainfall hurt seasonal brands.
  • Digital and modern trade channels now represent 38% of sales; premium products and quick commerce remain key growth engines going forward.
  • Management expects sustained double-digit international growth; seasonal brands should recover as weather normalizes and channel inventory clears.
  • Adjusted net profit excluding acquisition amortization rose 26.5%; reported profit pressured by RiteBite Max Protein acquisition-related charges.
Last Updated: 04-08-2026, 04:16 pm
Read Full Transcript

Earnings

Latest Release
04-08-2026
EPS / Forecast
3.70 / 3.90
Revenue / Forecast
14.37B / 14.5B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.92%
Dividend Yield
0.21%
Industry Median 0.93%
Annualised payout
1.20
Paid annually
5-Years Growth
+3.71%
Growth Streak

ZYDS Income Statement

Compare ZYDS to Peers and Sector

Metrics to compare
ZYDS
Peers
Sector
Relationship
P/E Ratio
93.2x19.1x11.3x
PEG Ratio
−2.210.230.03
Price/Book
3.0x2.8x1.5x
Price / LTM Sales
3.9x4.3x0.9x
Upside (Analyst Target)
11.9%24.5%24.0%
Fair Value Upside
Unlock7.6%13.2%Unlock

Zydus Wellness Limited engages in the development, production, marketing, and distribution of health and wellness products in Asia, the Middle East, Africa, the Oceania, Europe, and North America. It provides glucose powder under the Glucon-D brand; sugar substitute products under the Sugar Free Gold+, Sugar Free Natura, Sugar Free Green, and I'm lite brands; Milk-based nutrition drink products under the Complan brand; table spreads under the Nutralite brand; skin cleansing products under the Everyuth brand; hair color products under the Cuticolor brand; heat powder under the Nycil brand; and healthy eating products, such as snack bars, protein bars, breakfast cookies, and protein chips under the RiteBite brand. The company also offers plant-based supplements, vitamins and minerals, collagens, omegas, probiotics, and micronutrients for adults under the WeightWorld brand; health and wellness products, including multivitamin and vitamin D3 gummies, mushroom-based supplements, and other superfood supplements under the MaxMedix brand; and food supplements for dogs and cats under the Animigo brand. The company was formerly known as Carnation Nutra-Analogue Foods Limited and changed its name to Zydus Wellness Limited in January 2009. The company was founded in 1988 and is headquartered in Ahmedabad, India. Zydus Wellness Limited operates as a subsidiary of Zydus Lifesciences Limited.

Employees
1685
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
67.08M21.08%37.25B
Other Institutional Investors
228.87M71.93%127.10B
Public Companies & Retail Investors
22.21M6.98%12.34B
Total
318.16M100.00%176.69B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Zydus Family Trust69.61%22,14,63,34012,29,89,666
PPFAS Asset Management Private Limited7.27%2,31,35,5551,28,48,330

FAQ

What Is the Zydus Wellness (ZYDS) Share Price Today?

The Zydus Wellness share price today is 554.20.

What is the current Zydus Wellness (ZYDS) share price and day range?

As of 10-09-2026, the Zydus Wellness share price is 554.20, with a previous close of 554.20. The share price has ranged from 551.40 to 561.35 today, while the 52-week range spans from 367.55 to 611.85.

What Is the Zydus Wellness Market Cap?

As of today, Zydus Wellness market cap is 176.61B.

Does Zydus Wellness Pay Dividends? What's The Current Dividend Yield?

The Zydus Wellness dividend yield is 0.21%.

What Is Zydus Wellness's Earnings Per Share (TTM)?

The Zydus Wellness EPS (TTM) is 5.92.

When Is the Next Zydus Wellness Earnings Date?

Zydus Wellness will release its next earnings report on 14-11-2026.

From a Technical Analysis Perspective, Is ZYDS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

What Stock Exchange Does Zydus Wellness Trade On?

Zydus Wellness is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Zydus Wellness?

The stock symbol for Zydus Wellness is "ZYDS."

How Many Times Has Zydus Wellness Stock Split?

Zydus Wellness has split 1 times.

How Many Employees Does Zydus Wellness Have?

Zydus Wellness has 1685 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.